Literature DB >> 10512374

Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes.

J Ren1, L J Dominguez, J R Sowers, A J Davidoff.   

Abstract

We have recently demonstrated that adult rat ventricular myocytes maintained in a high glucose (HG) culture medium exhibit abnormalities in excitation-contraction coupling similar to myocytes from diabetic rats. Metformin, an insulin-sensitizing biguanide, enhances peripheral insulin action and lowers blood pressure in hyperinsulinemic animals, but its direct impact on cardiac function is not fully understood. To examine the role of metformin on HG-induced cardiac dysfunction at the cellular level, normal adult ventricular myocytes were cultured for 1 day in a serum-free insulin-containing medium with either normal glucose (5.5 mmol/l glucose) or HG (25.5 mmol/l glucose) in the presence or absence of metformin or the sulfonylurea glyburide. Mechanical properties were evaluated using a high-speed video-edge detection system, and intracellular Ca2+ transients were recorded in fura-2-loaded myocytes. As previously reported, culturing myocytes in HG depresses peak shortening, prolongs time to 90% relengthening, and slows Ca2+ transient decay. Culturing cells with metformin (50 micromol/l) prevented the HG-induced abnormalities in relaxation without ameliorating depressed peak-shortening amplitudes. Incubation of the cells with metformin also prevented slower intracellular Ca2+ clearing induced by HG. However, the HG-induced relaxation defects were not improved by glyburide (50-300 micromol/l). Interestingly, metformin also improved HG-induced relaxation abnormalities in the absence of insulin, whereas it failed to protect against HG in the presence of the tyrosine kinase inhibitor genistein (50 micromol/l). These data demonstrate that, unlike glyburide, metformin provides cardioprotection against HG-induced abnormalities in myocyte relaxation, perhaps through tyrosine kinase-dependent changes in intracellular Ca2+ handling, independent of its insulin sensitizing action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512374     DOI: 10.2337/diabetes.48.10.2059

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  Diabetic cardiomyopathy: do women differ from men?

Authors:  Jun Ren; Asli F Ceylan-Isik
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

Review 2.  Novel therapeutic targets for the treatment of heart failure.

Authors:  Juan Tamargo; José López-Sendón
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

3.  Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress.

Authors:  Wai Ho Tang; Wing Tim Cheng; Gennadi M Kravtsov; Xiao Yong Tong; Xiu Yun Hou; Sookja K Chung; Stephen Sum Man Chung
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-23       Impact factor: 4.249

4.  Use of Metformin in Patients with Kidney and Cardiovascular Diseases.

Authors:  David Klachko; Adam Whaley-Connell
Journal:  Cardiorenal Med       Date:  2011-04-14       Impact factor: 2.041

5.  Prevalence of 'borderline' values of cardiovascular risk factors in the clinical practice of general medicine in Italy: results of the BORDERLINE study.

Authors:  Giuliano Tocci; Andrea Ferrucci; Jasmine Passerini; Maurizio Averna; Paolo Bellotti; Graziella Bruno; Francesco Cosentino; Gaetano Crepaldi; Cristina Giannattasio; Maria Grazia Modena; Giulio Nati; Antonio Tiengo; Bruno Trimarco; Diego Vanuzzo; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-06-01

6.  Diabetic cardiomyocyte dysfunction and myocyte insulin resistance: role of glucose-induced PKC activity.

Authors:  Amy J Davidoff; Michael B Davidson; Marybeth W Carmody; Mari-Elena Davis; Jun Ren
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

7.  Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway.

Authors:  Min Wang; Wen-bin Zhang; Jun-hui Zhu; Guo-sheng Fu; Bin-quan Zhou
Journal:  Acta Pharmacol Sin       Date:  2009-07-13       Impact factor: 6.150

8.  Determinants of subclinical diabetic heart disease.

Authors:  Z Y Fang; R Schull-Meade; M Downey; J Prins; T H Marwick
Journal:  Diabetologia       Date:  2005-01-08       Impact factor: 10.122

9.  Targeted deletion of PTEN in cardiomyocytes renders cardiac contractile dysfunction through interruption of Pink1-AMPK signaling and autophagy.

Authors:  Nathan D Roe; Xihui Xu; Machender R Kandadi; Nan Hu; Jiaojiao Pang; Mary C M Weiser-Evans; Jun Ren
Journal:  Biochim Biophys Acta       Date:  2014-09-16

Review 10.  Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Jun Ren; Ne N Wu; Shuyi Wang; James R Sowers; Yingmei Zhang
Journal:  Physiol Rev       Date:  2021-05-05       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.